larkspur

A larkspur specimen in bloom at Beal Botanical Garden. Known for their toxicity, injurious plants such as larkspur and wolfsbane have been leveraged by humans for millennia for their medicinal potential. Credit: Paul Henderson

Scientists Finally Mapped How Wolfsbane and Larkspur Build Their Toxic Compounds

In A Nutshell

  • Scientists mapped six enzymes that wolfsbane and its garden-flower relative, larkspur, use to build toxic compounds with potential uses against pain, cancer, and malaria.
  • The discovery came from a chance meeting: labs at Michigan State studying larkspur and the Czech Academy of Sciences studying wolfsbane crossed paths at a conference and joined forces.
  • The nitrogen inside these toxins comes from an ordinary, everyday molecule called ethanolamine, not the compound scientists had long assumed, even in cases like aconitine.
  • Researchers rebuilt part of the pathway inside tobacco plants and produced a working alkaloid called atisinium, a first step toward growing these compounds without harvesting wild roots.

Two plants potent enough to cause paralysis in the tiniest doses are also being eyed as sources of new medicine for various ailments like pain, cancer, and malaria. For over 2,000 years, healers have used wolfsbane as both cure and poison. Its garden-flower cousin larkspur makes many of the same compounds. Scientists have now mapped, for the first time, six molecular steps behind them.

Published in the journal Molecular Plant, the findings center on the Aconitum and Delphinium genera, which store these compounds mainly in their roots. Traditional Chinese medicine has used processed wolfsbane root, called “Fuzi,” for at least 2,000 years, and aconitine was first isolated in 1833. Its six interlocking rings have beaten every chemist who has tried to rebuild it since.

“These plants have been used in different forms of medicine throughout the world for thousands of years,” said Garret Miller, co-first author of the paper and now an assistant professor at the University of Michigan-Flint. “We know they interact with our bodies in so many ways, and understanding how to create them can help provide totally new routes of testing.”

Two Labs Chasing the Same Toxin Joined Forces

Michigan State University’s Björn Hamberger had already set his sights on larkspur when he crossed paths with a group chasing the same chemistry in wolfsbane, led by Tomáš Pluskal at the Czech Academy of Sciences, at a conference in Barcelona. The two teams joined forces. “It’s joining up that always leads to the best science,” said Hamberger, the James K. Billman Endowed Professor at MSU.

Cross-Species Gene Comparisons Narrowed 284 Candidates to Six

To figure out how these plants build such compounds, researchers sequenced genetic activity across multiple tissues from Delphinium grandiflorum, Aconitum plicatum, and Aconitum lycoctonum, then added public data from four more Aconitum species, seven species total. “You can imagine a biosynthetic pathway almost as an assembly line,” said Miller, the paper’s co-first author. “If you have ten steps in a row needed to build a finished product, and suddenly one quits, the next steps can’t happen.”

By checking which genes were active in the roots, where these compounds build up, and matching genes across all seven species, researchers narrowed a huge list of candidates to something testable. One group of enzymes started as 284 possibilities in a single species. Cross-species matching cut that to just six.

Testing meant temporarily inserting candidate genes into tobacco plants, a standard method for checking whether a gene triggers an expected reaction. The team confirmed two enzymes that build the molecule’s basic carbon frame, three that add oxygen, and a sixth that threads nitrogen into the structure, the step turning a plain plant chemical into a true alkaloid.

That sixth enzyme, named DAS, was the most surprising find, spotted through gene activity in wolfsbane roots at different growth stages. DAS belongs to a group of proteins nobody had pinned a job to before, though distant relatives turn up in green algae and other plants.

wolfsbane infographic
Researchers found the entry steps to a 200-year-old plant chemistry mystery, with real promise for new natural medicines. (Image by StudyFinds)

The Nitrogen Surprise at the Heart of Wolfsbane Chemistry

Perhaps the most counterintuitive finding involves how nitrogen, the element that turns an ordinary plant compound into an alkaloid, gets built into the molecule.

Looking at the finished structure of most of these compounds, including aconitine, the nitrogen appears attached through a small chemical piece called ethylamine. That was the obvious guess, and it turned out wrong. When researchers fed the plants tagged versions of both ethylamine and a related building block called ethanolamine, only ethanolamine turned up in the finished products, confirmed by a second experiment using lab-grown plant tissue fed the same tagged molecules for a month. Out of 61 compounds detected, 41 showed signs of ethanolamine and none showed ethylamine, including one signal tentatively identified as aconitine. Ethanolamine already floats around inside plant cells as part of their membranes, and DAS appears to have evolved specifically to grab that everyday molecule and stitch it into the toxin’s structure.

Tobacco Plants Produced a Bioactive Alkaloid Intermediate

Using all six enzymes together, the team rebuilt the pathway in tobacco plants and generated detectable atisinium, a compound previously reported to fight malaria parasites. This covered only the earliest steps and one intermediate, not full-scale manufacturing, but it shows these toxins could someday be grown in engineered organisms rather than dug up from slow-growing roots. “In an ideal scenario, this could eventually help create new drugs inspired by these natural products,” Mutabdžija said.

Researchers also confirmed the six-step process is shared by both genera, meaning the same steps operate in wolfsbane and larkspur despite roughly 27 million years of evolutionary separation. Hundreds of these compounds exist in nature, and a patent application tied to producing them has already been filed by several team members.

“Many of the medicines we use today either come directly from plants or are inspired by plant chemistry,” said Lana Mutabdžija, a graduate student at the Czech Academy of Sciences and co-first author of the paper. For a class of molecules first studied nearly two centuries ago, wolfsbane and larkspur have guarded their manufacturing secrets well. Now, at least for the first crucial steps, scientists finally have the recipe.


Disclaimer: This article is based on findings from a peer-reviewed study and is intended for general informational purposes. It does not constitute medical advice. Wolfsbane and related plants contain compounds that are acutely toxic and should never be handled, ingested, or self-administered.


Paper Notes

Study Limitations

The authors acknowledge several limitations. The study characterizes only the initial steps of the diterpenoid alkaloid biosynthetic pathway; the many additional enzymatic steps required to produce more complex members of this chemical family, such as aconitine, remain unknown. Direct in-plant testing was limited to transient transformation techniques not yet compatible with root tissue, where these compounds naturally accumulate. Attempts to establish hairy root cultures for feeding experiments were unsuccessful, and sterile plant cuttings did not remain viable, which is why callus cultures were used instead. Some enzyme functions could not be definitively confirmed due to challenges with product separation and limited substrate quantities. The callus culture feeding experiments detected many putative diterpenoid alkaloids computationally, but the lack of available reference standards for most of these compounds means the identifications are predictions rather than confirmed matches. Interference from the tobacco plant host used in the heterologous expression experiments also cannot be entirely ruled out.

Funding and Disclosures

Garret P. Miller was supported by a fellowship from Michigan State University under the Training Program in Plant Biotechnology for Health and Sustainability (T32-GM110523). Lana Mutabdžija-Nedelcheva is co-financed by the governments of Czechia, Hungary, Poland, and Slovakia through Visegrad Grant 52410140 from the International Visegrad Fund. Tomáš Pluskal was supported by the Czech Science Foundation grant 21-11563M. Björn Hamberger and Trine B. Andersen acknowledge the US Department of Energy Great Lakes Bioenergy Research Center Cooperative Agreement DE-SC0018409. Hamberger also acknowledges support from AgBioResearch (MICL02454) and a named endowment. Garret P. Miller, Björn Hamberger, Imani Pascoe, and Kathryn Van Winkle are listed as inventors on a US patent application (serial no. 18/357,767) related to the production of diterpenoid alkaloids.

Publication Details

Paper Title: Characterization of the entry steps in diterpenoid alkaloid biosynthesis | Authors: Garret P. Miller, Lana Mutabdžija-Nedelcheva, Trine B. Andersen, Imani Pascoe, Kathryn Van Winkle, Maryam Sabbaghan, Alexandre Bouillé, Tomáš Iliaš, Andrej Tekel, Tomáš Pluskal, and Björn Hamberger | Affiliations: Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA; Green Chemistry and Biochemistry, University of Michigan-Flint, Flint, MI, USA; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czechia; Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czechia; Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czechia | Journal: Molecular Plant, Volume 19, pages 1711-1725, August 3, 2026 | DOI: https://doi.org/10.1016/j.molp.2026.05.022


About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor